Header

UZH-Logo

Maintenance Infos

Cardiac-resynchronization therapy in heart failure with a narrow QRS complex


Ruschitzka, F; Abraham, W T; Singh, J P; Bax, J J; Borer, J S; Brugada, J; Dickstein, K; Ford, I; Gorcsan, J; Gras, D; Krum, H; Sogaard, P; Holzmeister, J (2013). Cardiac-resynchronization therapy in heart failure with a narrow QRS complex. New England Journal of Medicine, 369(15):1395-1405.

Abstract

Background Cardiac-resynchronization therapy (CRT) reduces morbidity and mortality in chronic systolic heart failure with a wide QRS complex. Mechanical dyssynchrony also occurs in patients with a narrow QRS complex, which suggests the potential usefulness of CRT in such patients. Methods We conducted a randomized trial involving 115 centers to evaluate the effect of CRT in patients with New York Heart Association class III or IV heart failure, a left ventricular ejection fraction of 35% or less, a QRS duration of less than 130 msec, and echocardiographic evidence of left ventricular dyssynchrony. All patients underwent device implantation and were randomly assigned to have CRT capability turned on or off. The primary efficacy outcome was the composite of death from any cause or first hospitalization for worsening heart failure. Results On March 13, 2013, the study was stopped for futility on the recommendation of the data and safety monitoring board. At study closure, the 809 patients who had undergone randomization had been followed for a mean of 19.4 months. The primary outcome occurred in 116 of 404 patients in the CRT group, as compared with 102 of 405 in the control group (28.7% vs. 25.2%; hazard ratio, 1.20; 95% confidence interval [CI], 0.92 to 1.57; P=0.15). There were 45 deaths in the CRT group and 26 in the control group (11.1% vs. 6.4%; hazard ratio, 1.81; 95% CI, 1.11 to 2.93; P=0.02). Conclusions In patients with systolic heart failure and a QRS duration of less than 130 msec, CRT does not reduce the rate of death or hospitalization for heart failure and may increase mortality. (Funded by Biotronik and GE Healthcare; EchoCRT ClinicalTrials.gov number, NCT00683696 .).

Abstract

Background Cardiac-resynchronization therapy (CRT) reduces morbidity and mortality in chronic systolic heart failure with a wide QRS complex. Mechanical dyssynchrony also occurs in patients with a narrow QRS complex, which suggests the potential usefulness of CRT in such patients. Methods We conducted a randomized trial involving 115 centers to evaluate the effect of CRT in patients with New York Heart Association class III or IV heart failure, a left ventricular ejection fraction of 35% or less, a QRS duration of less than 130 msec, and echocardiographic evidence of left ventricular dyssynchrony. All patients underwent device implantation and were randomly assigned to have CRT capability turned on or off. The primary efficacy outcome was the composite of death from any cause or first hospitalization for worsening heart failure. Results On March 13, 2013, the study was stopped for futility on the recommendation of the data and safety monitoring board. At study closure, the 809 patients who had undergone randomization had been followed for a mean of 19.4 months. The primary outcome occurred in 116 of 404 patients in the CRT group, as compared with 102 of 405 in the control group (28.7% vs. 25.2%; hazard ratio, 1.20; 95% confidence interval [CI], 0.92 to 1.57; P=0.15). There were 45 deaths in the CRT group and 26 in the control group (11.1% vs. 6.4%; hazard ratio, 1.81; 95% CI, 1.11 to 2.93; P=0.02). Conclusions In patients with systolic heart failure and a QRS duration of less than 130 msec, CRT does not reduce the rate of death or hospitalization for heart failure and may increase mortality. (Funded by Biotronik and GE Healthcare; EchoCRT ClinicalTrials.gov number, NCT00683696 .).

Statistics

Citations

261 citations in Web of Science®
275 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

62 downloads since deposited on 01 Nov 2013
28 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Cardiology
Dewey Decimal Classification:610 Medicine & health
Language:English
Date:2013
Deposited On:01 Nov 2013 09:10
Last Modified:07 Dec 2017 23:18
Publisher:Massachusetts Medical Society
ISSN:0028-4793
Additional Information:From New England Journal of Medicine, Ruschitzka, F; Abraham, W T; Singh, J P; Bax, J J; Borer, J S; Brugada, J; Dickstein, K; Ford, I; Gorcsan, J; Gras, D; Krum, H; Sogaard, P; Holzmeister, J (2013). Cardiac-resynchronization therapy in heart failure with a narrow QRS complex. New England Journal of Medicine, 369(15):1395-1405. Copyright © 2013 Massachusetts Medical Society. Reprinted with permission.
Free access at:Publisher DOI. An embargo period may apply.
Publisher DOI:https://doi.org/10.1056/NEJMoa1306687
PubMed ID:23998714

Download

Download PDF  'Cardiac-resynchronization therapy in heart failure with a narrow QRS complex'.
Preview
Content: Published Version
Filetype: PDF
Size: 701kB
View at publisher